Spark Therapeutics Uk Ltd
10309997
Some Concerns
- No accounts filed in last 18 months (-5)
- Loss before tax (-10)
- Going concern doubt noted in accounts (-10)
Details
Previously known as
Compliance
Last accounts
31/12/2024
small
Next accounts due
30/09/2026
Confirmation statement
Last: 03/08/2025
Due 17/08/2026
Industry
Officers
director · Since 01/10/2025
ISRAELI · ENGLAND · Age 42
Also on 3 other boards
secretary · Since 01/10/2025
Former
corporate secretary · Resigned 12/04/2017
director · Resigned 12/04/2017
director · Resigned 01/01/2019
director · Resigned 17/12/2019
director · Resigned 25/04/2022
director · Resigned 25/04/2022
director · Resigned 01/11/2022
corporate secretary · Resigned 24/04/2024
director · Resigned 15/12/2025
Persons with Significant Control
Spark Therapeutics International Holdings, Inc
3737, Market Street, Philadelphia, PA 19104
Notified 03/08/2016
Change History
Active
Private Limited Company
6 SHIRE PARK
WELWYN GARDEN CITY
CompanyRankvs 19093+ SIC 86900 peers53
Show leaderboard
How is this score calculated?
Net worth compared to all companies in the same SIC code with published accounts. Top quartile earns the full 25 points.
Workforce size relative to sector peers from the most recent accounts. A larger team generally signals commercial scale.
Current assets ÷ current liabilities. A ratio above 2× earns full marks; between 1–2× scores partially; below 0.5× scores minimal points.
One point per year of operation since incorporation, capped at 15. Older companies have a proven track record.
Full 15 points when both annual accounts and confirmation statement are filed on time. Points are deducted for each overdue filing.
Risk deductions
Going concern doubt: -10 pts
Maximum score is 100. Deductions apply for insolvency history, outstanding charges, going concern doubt, or disqualified officers.
Going Concern Doubt
we have not identified any material uncertainties relating to events or conditions that, individually or collectively, may cast significant doubt on the company's ability to continue as a going concern for a period of at least twelve months from when the financial statements are authorised for issue. Our responsibilities and the responsibilities of the director with respect to going concern are de
Key FinancialsYear ending 31/12/2023
Turnover
£1.4M
Annual revenue
Net Worth
£1
Balance sheet strength
Cash
£91k
Cash in the bank
Profit Before Tax
-£87k
Bottom line earnings
Net Current Assets
£4.5M
Working capital
Current Assets
£4.5M
Current Liabilities
£42k
Debtors
£4.4M
Admin Expenses
£1.3M
Operating Profit
£132k
Profit After Tax
-£65k
Balance Sheet
EstimatesDerived
| Year | Current Ratio |
|---|---|
| 2023 | 105.92 |
Derived from filed accounts. Not audited figures.